438 research outputs found

    Analysis of small-diameter wood supply in northern Arizona - Final report

    Get PDF
    Forest management to restore fire-adapted ponderosa pine ecosystems is a central priority of the Southwestern Region of the USDA Forest Service. Appropriately-scaled businesses are apt to play a key role in achieving this goal by harvesting, processing and selling wood products, thereby reducing treatment costs and providing economic opportunities. The manner in which treatments occur across northern Arizona, with its multiple jurisdictions and land management areas, is of vital concern to a diversity of stakeholder groups. To identify a level of forest thinning treatments and potential wood supply from restoration byproducts, a 20-member working group representing environmental non-governmental organizations (NGOs), private forest industries, local government, the Ecological Restoration Institute at Northern Arizona University (NAU), and state and federal land and resource management agencies was assembled. A series of seven workshops supported by Forest Ecosystem Restoration Analysis (ForestERA; NAU) staff were designed to consolidate geographic data and other spatial information and to synthesize potential treatment scenarios for a 2.4 million acre analysis area south of the Grand Canyon and across the Mogollon Plateau. A total of 94% of the analysis area is on National Forest lands. ForestERA developed up-to-date remote sensing-based forest structure data layers to inform the development of treatment scenarios, and to estimate wood volume in three tree diameter classes of 16" diameter at breast height (dbh, 4.5' above base). For the purposes of this report, the group selected a 16" dbh threshold due to its common use within the analysis landscape as a break point differentiating "small" and "large" diameter trees in the ponderosa pine forest type. The focus of this study was on small-diameter trees, although wood supply estimates include some trees >16" dbh where their removal was required to meet desired post-treatment conditions.4 There was no concurrence within the group that trees over 16" dbh should be cut and removed from areas outside community protection management areas (CPMAs)..

    Independent large scale duplications in multiple M. tuberculosis lineages overlapping the same genomic region

    Get PDF
    Mycobacterium tuberculosis, the causative agent of most human tuberculosis, infects one third of the world's population and kills an estimated 1.7 million people a year. With the world-wide emergence of drug resistance, and the finding of more functional genetic diversity than previously expected, there is a renewed interest in understanding the forces driving genome evolution of this important pathogen. Genetic diversity in M. tuberculosis is dominated by single nucleotide polymorphisms and small scale gene deletion, with little or no evidence for large scale genome rearrangements seen in other bacteria. Recently, a single report described a large scale genome duplication that was suggested to be specific to the Beijing lineage. We report here multiple independent large-scale duplications of the same genomic region of M. tuberculosis detected through whole-genome sequencing. The duplications occur in strains belonging to both M. tuberculosis lineage 2 and 4, and are thus not limited to Beijing strains. The duplications occur in both drug-resistant and drug susceptible strains. The duplicated regions also have substantially different boundaries in different strains, indicating different originating duplication events. We further identify a smaller segmental duplication of a different genomic region of a lab strain of H37Rv. The presence of multiple independent duplications of the same genomic region suggests either instability in this region, a selective advantage conferred by the duplication, or both. The identified duplications suggest that large-scale gene duplication may be more common in M. tuberculosis than previously considere

    Territorial Self-Governance and Proportional Representation:Reducing the Risk of Territory-Centred Intrastate Violence

    Get PDF
    After decades of scholarship, there is still little agreement about the usefulness of territorial self-governance in managing territory-centred conflicts. We argue that the effectiveness of territorial self-governance as a tool of territory-centred conflict management increases when combined with a proportional representation (PR) electoral system for the national legislature in basically open political regimes, but not when combined with a parliamentary form of government at the centre. We propose that the combination of territorial self-governance and PR in at least minimally democratic regimes has most conflict-reducing potential, as both institutions follow a logic of widening the input side of representative politics. We find empirical support for this proposition using binary time-series cross-section analysis is found. Our findings highlight the need to consider not just the number but, more importantly, the type of power-sharing institutions that are combined with each other when looking for ways to reduce the risk of territory-centred intrastate violence

    TB database: an integrated platform for tuberculosis research

    Get PDF
    The effective control of tuberculosis (TB) has been thwarted by the need for prolonged, complex and potentially toxic drug regimens, by reliance on an inefficient vaccine and by the absence of biomarkers of clinical status. The promise of the genomics era for TB control is substantial, but has been hindered by the lack of a central repository that collects and integrates genomic and experimental data about this organism in a way that can be readily accessed and analyzed. The Tuberculosis Database (TBDB) is an integrated database providing access to TB genomic data and resources, relevant to the discovery and development of TB drugs, vaccines and biomarkers. The current release of TBDB houses genome sequence data and annotations for 28 different Mycobacterium tuberculosis strains and related bacteria. TBDB stores pre- and post-publication gene-expression data from M. tuberculosis and its close relatives. TBDB currently hosts data for nearly 1500 public tuberculosis microarrays and 260 arrays for Streptomyces. In addition, TBDB provides access to a suite of comparative genomics and microarray analysis software. By bringing together M. tuberculosis genome annotation and gene-expression data with a suite of analysis tools, TBDB (http://www.tbdb.org/) provides a unique discovery platform for TB research

    TB database: an integrated platform for tuberculosis research

    Get PDF
    The effective control of tuberculosis (TB) has been thwarted by the need for prolonged, complex and potentially toxic drug regimens, by reliance on an inefficient vaccine and by the absence of biomarkers of clinical status. The promise of the genomics era for TB control is substantial, but has been hindered by the lack of a central repository that collects and integrates genomic and experimental data about this organism in a way that can be readily accessed and analyzed. The Tuberculosis Database (TBDB) is an integrated database providing access to TB genomic data and resources, relevant to the discovery and development of TB drugs, vaccines and biomarkers. The current release of TBDB houses genome sequence data and annotations for 28 different Mycobacterium tuberculosis strains and related bacteria. TBDB stores pre- and post-publication gene-expression data from M. tuberculosis and its close relatives. TBDB currently hosts data for nearly 1500 public tuberculosis microarrays and 260 arrays for Streptomyces. In addition, TBDB provides access to a suite of comparative genomics and microarray analysis software. By bringing together M. tuberculosis genome annotation and gene-expression data with a suite of analysis tools, TBDB (http://www.tbdb.org/) provides a unique discovery platform for TB research

    Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer

    Full text link
    Eighty-six patients with advanced colorectal, gastric or pancreatic carcinoma and no prior exposure to chemotherapy were treated with brequinar sodium. Brequinar was administered at a median weekly dose of 1200 mg/m 2 intravenously. The toxicity was moderate, with thirty patients (35%) experiencing grade 3 or 4 toxicity. Objective responses were observed in 1/32 evaluable colorectal and 2/29 evaluable gastric carcinoma patients. There were no objective responses in 17 evaluable pancreatic cancer patients. We conclude that, at this dose and schedule, brequinar does not have sufficient activity in these gastrointestinal malignancies to warrant further evaluation.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/45168/1/10637_2004_Article_BF00873913.pd

    Population-Based Surveillance for Invasive Pneumococcal Disease in Homeless Adults in Toronto

    Get PDF
    BACKGROUND: Identification of high-risk populations for serious infection due to S. pneumoniae will permit appropriately targeted prevention programs. METHODS: We conducted prospective, population-based surveillance for invasive pneumococcal disease and laboratory confirmed pneumococcal pneumonia in homeless adults in Toronto, a Canadian city with a total population of 2.5 M, from January 1, 2002 to December 31, 2006. RESULTS: We identified 69 cases of invasive pneumococcal disease and 27 cases of laboratory confirmed pneumococcal pneumonia in an estimated population of 5050 homeless adults. The incidence of invasive pneumococcal disease in homeless adults was 273 infections per 100,000 persons per year, compared to 9 per 100,000 persons per year in the general adult population. Homeless persons with invasive pneumococcal disease were younger than other adults (median age 46 years vs 67 years, P<.001), and more likely than other adults to be smokers (95% vs. 31%, P<.001), to abuse alcohol (62% vs 15%, P<.001), and to use intravenous drugs (42% vs 4%, P<.001). Relative to age matched controls, they were more likely to have underlying lung disease (12/69, 17% vs 17/272, 6%, P = .006), but not more likely to be HIV infected (17/69, 25% vs 58/282, 21%, P = .73). The proportion of patients with recurrent disease was five fold higher for homeless than other adults (7/58, 12% vs. 24/943, 2.5%, P<.001). In homeless adults, 28 (32%) of pneumococcal isolates were of serotypes included in the 7-valent conjugate vaccine, 42 (48%) of serotypes included in the 13-valent conjugate vaccine, and 72 (83%) of serotypes included in the 23-valent polysaccharide vaccine. Although no outbreaks of disease were identified in shelters, there was evidence of clustering of serotypes suggestive of transmission of pathogenic strains within the homeless population. CONCLUSIONS: Homeless persons are at high risk of serious pneumococcal infection. Vaccination, physical structure changes or other program to reduce transmission in shelters, harm reduction programs to reduce rates of smoking, alcohol abuse and infection with bloodborne pathogens, and improved treatment programs for HIV infection may all be effective in reducing the risk
    corecore